📚 Syllabus & Course Curriculum
Drug Discovery & Pharmaceutical Sciences
Module-by-module breakdown of AI-Powered Organoid Drug Discovery & Data Analytics, from foundations to a certified capstone project.
Models
• Patient-derived and iPSC-derived organoids and what each preserves
• Matrigel batch variability as a dominant and under-reported source of noise
• Where organoids beat 2D culture, and what they still fail to model
Assays
• Plate format, seeding density and edge effects in 3D culture
• Viability readouts in 3D: CellTiter-Glo 3D versus imaging-based measures
• Z-prime and replicate structure — a screen that fails QC is not salvageable later
Imaging
• Confocal and light-sheet acquisition trade-offs for organoid volumes
• Segmentation with Cellpose or StarDist and the retraining usually required
• Morphological feature extraction and the batch effects hidden in imaging runs
Analytics
• Dose-response fitting, IC50 and the distinction from AUC-based metrics
• Handling heterogeneity between organoid lines rather than averaging it away
• Machine learning on morphological profiles and the small-n overfitting trap
Translation
• Retrospective organoid-to-patient concordance studies and their reported accuracy
• Turnaround time as the binding constraint on clinical use
• Reporting standards and reproducibility across organoid laboratories
Earn government-registered certification in AI-Powered Organoid Drug Discovery & Data Analytics
e-Certificate and e-Marksheet issued on successful completion.
